Scientists Investigate Veto Cell Technology to Treat Blood Cancers, Bone Marrow Transplants

December 3, 2014

(News-Medical) – Overcoming graft rejection is the main obstacle when it comes to stem cell regeneration or organ transplantation. Current treatment includes the use of systemic immunosuppression, which leaves the patient at risk for opportunistic infections. Scientists now are investigating whether Veto Cell technology, which selectively tunes immune response, can change how immunologists treat blood cancers and bone marrow transplants, as well as the process of how organs are repaired and new ones are regenerated.